icd10free.comPowered by Curo

ICD-10 Coding for European Dexamethasone Study(Z00.6, C71.9, G00.1)

Save

Explore the ICD-10 coding and documentation requirements for the European Dexamethasone Study, including key codes, pitfalls, and billing considerations.

Also known as:
EDSDexamethasone Clinical Trial
Related ICD-10 Code Ranges

Complete code families applicable to European Dexamethasone Study

Z00-Z99Primary Range

Factors influencing health status and contact with health services

→
Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
Z00.6Encounter for examination for normal comparison and control in clinical research program
Z51.89Encounter for other specified aftercare
C71.9Malignant neoplasm of brain, unspecified
Primary ICD-10-CM Codes
Encounter for examination for normal comparison and control in clinical research program
Z00.6Billable
Differential Codes

Alternative codes to consider when ruling out similar conditions

Pneumococcal meningitisG00.1

Documentation & Coding Risks

Avoid these common issues when documenting European Dexamethasone Study.

Omitting trial documentation

Impact

Clinical: Inaccurate treatment records, Regulatory: Non-compliance with trial protocols, Financial: Potential denial of trial-related claims

Mitigation

Verify trial documentation before coding

Using Z51.11 for dexamethasone monotherapy.

Impact

Reimbursement: Incorrect DRG assignment leading to payment issues., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.

Mitigation

Use Z51.89 for non-chemotherapy dexamethasone use.

Trial Documentation

Impact

Lack of documentation for trial participation.

Mitigation

Ensure all trial-related documents are filed.

Frequently Asked Questions

Related condition guides

Documentation requirements, coding pitfalls and FAQs for conditions coded with Z00.6.